2Toussaint JF, Southern JF, KantorHL, et al. Behavior of atherosclerotic plaque components after in vitro angioplasty andatherectomy studied by high filed MR imaging. Magn Reson Imaging, 1998, 16(2):175～183.
3Pasterkamp G, Schoneveld AH, van der Wal AC, et al. Inflammation of theatherosclerotic cap and shouler of the plaque is a common and locally observed feature inunruptured plaques of femoral and coronary arteries. Arterioscler Thromb Vasc Biol, 1999,19(1):54～58.
4Pasterkamp G, Schoneveld AH, van der Wal AC, et al. Relation of arterial geometryto luminal narrowing and histoligic markers for plaque vulnerability: the remodelingparadox. J Am Coll Cardiol, 1998, 32(3):655～662.
5Kullo IJ, Edwards WD, Schwartz RS. Vulnerable plaque: Pathobioligy and clinicalimplications. Ann Intern Med, 1998, 129:1 050～1 060.
6Curci JA, Liao S, Huffman MD, et al. Expression and localization of macrophageelastase(matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest, 1998,102(1):1 900～1 910.
7Wallner K, Li C, Shah PK, et al. Tenascin C is expressed in macrophage-rich humancoronary atherosclerotic plaque. Circulation, 1999, 99(10):1 284～1 289.
8Schonbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinaseexpression in human vascular smooth muscle cells by T lymphocytes: a role for CD40signaling in laque reuture? Circ Res, 1997, 81:448～454.
9Muhlestein JB. Bacterial infections and atherosclerosis. J Investig Med, 1998,46(8):396～402.
10Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. ArteriosclerThromb Vasc Biol, 1998, 18(10):1 523～1 533.
